Should You Buy WUXI BIO (02269) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast 02269 stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast 02269 stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 29.700
Low
0
Averages
0
High
0
0
Current: 29.700
Low
0
Averages
0
High
0
HSBC
HSBC Global Investment Research
Buy
maintain
$44
AI Analysis
2026-06-08
New
Reason
HSBC
HSBC Global Investment Research
Price Target
$44
AI Analysis
2026-06-08
New
maintain
Buy
Reason
HSBC Global Investment Research has raised its revenue forecasts for WUXI BIO for 2027 to 2028 by 8% to 17% due to the company's interim growth guidance exceeding expectations. The broker is optimistic about the company's growth outlook, supported by strong growth momentum in its manufacturing business and a significant increase in integrated projects. The target price has been increased from HKD44 to HKD45.8, and the Buy rating is maintained.
Nomura
Buy
maintain
$50.54
2026-06-01
Reason
Nomura
Price Target
$50.54
2026-06-01
maintain
Buy
Reason
Nomura believes that WUXI BIO's recent share repurchase plan and positive business update indicate strong operations and that the stock is undervalued. The company has set ambitious revenue growth targets for 2027-29, and despite a recent decline in share price, the management's actions signal confidence in the company's value. Therefore, Nomura maintains a Buy rating with a target price of HKD50.54.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 02269
